Annie McGuire, the Executive Vice President of Veracyte, has executed a sale of company stock valued at $158,000. This transaction is part of her financial management strategy and reflects her holdings in the biotechnology firm. The sale was disclosed in accordance with regulatory requirements governing insider trading and stock transactions by corporate executives.
Don't miss out on breaking stories and in-depth articles.
